Expression of transforming growth factor β1, β2, and β3 in multinodular goiters and differentiated thyroid carcinomas: A comparative study

Thyroid

Volumn 9, Issue 2, 1999, Pages 119-125

  Kimura, Edna Teruko ^a,c   Kopp, Peter ^a,b   Zbaeren, Jakob ^a   Asmis, Lars M ^a   Ruchti, Charles ^a   Maciel, Rui M B ^d   Studer, Hugo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THYROID CARCINOMA; TISSUE DISTRIBUTION;

EID: 0033046093     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.119     Document Type: Article

References (35)

1. Roberts A, Sporn M 1991 The transforming growth factor-βs. In: Sporn M, Roberts A (eds) Peptide Growth Factors and their Receptors I. Springer-Verlag, New York, pp 419-472.
2. Derynck R, Feng XH 1997 TGF-beta receptor signaling. Biochim Biophys Acta 1333:F105-150.
3. 2. Mol Endocrinol 3:1977-1986.
4. 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
5. Geng Y, Weinberg R 1993 Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90:10315-10319.
6. Morris J III, Ranganathan G, Hay I, Nelson R, Jiang N 1988 The effects of TGFβ on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 123:1385-1394.
7. Tsushima T, Arai M, Saji M, Ohba Y, Marakami H, Ohmura E, Sato K, Shizume K 1988 Effect on TGFβ on DNA synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 123:1187-1194.
8. Grubeck-Loebenstein B, Buchan G, Sadeghi R, Kissonerghis M, Londei M, Turner M, Pirich K, Nierdele B, Kassal H, Waldhausl W, Feldmann M 1989 Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83:764-770.
9. 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:113-121.
10. Ohta K, Pang X, Berg L, Hershman J 1996 Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab 81:2607-2612.
11. Heldin CH, Miyazono K, ten Dijke P 1998 TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
12. Massagué J 1998 TGFβ signal transduction. Annu Rev Biochem 67:753-791.
13. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC 1993 Association of transforming growth factor-β 1 with prostate cancer: An immunohistochemical study. Hum Pathol 24:4-9.
14. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB 1992 Localization of transforming growth factor β isotopes in lesions of the human breast. Hum Pathol 23:13-20.
15. Jasani B, Wyllie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D 1990 Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2:149-155.
16. Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y 1998 Clinicopathological and immunohistochemical studies of papillary microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22:731-737.
17. Morosini P, Taccaliti A, Di Loreto C, Arnaldi G, Faloia E, Giacchetti G, Mantero F 1994 Transforming growth factor-beta 1 is more expressed in thyroid follicular adenoma than in normal tissue. J Endocrinol Invest 17:335-340.
18. van der Laan B, Freeman J, Asa S 1995 Expression of growth factors and growth factor receptors in normal and tumorous thyroid tissues. Thyroid 5:67-73.
19. 1 immunohistochemistry in goiter: Comparison of patients with recurrence or no recurrence. Thyroid 6:417-422.
20. Hedinger C, Williams ED, Sobin LH 1988 Histological classification of thyroid tumours. In: Hedinger C (ed) Histological typing of thyroid tumours. WHO. International histological classification of tumours. Second edition. Springer-Verlag, Berlin, pp 3-18.
21. Studer H, Gerber H, Zbaeren J, Peter HJ 1992 Histomorphological and immunohistochemical evidence that human multinodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab 74:1151-1158.
22. Aeschimann S, Kopp PA, Kimura ET, Zbaeren J, Tobler A, Fey MF, Studer H 1993 Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 77:846-851.
23. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gilett CE, Camplejohn R, Dover R, Waseem NH, Lane DP 1990 Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285-294.
24. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697.
25. Fagin JA 1992 Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab 75:1398-1400.
26. Farid NR, Shi Y, Zou M 1994 Molecular basis of thyroid cancer. Endocr Rev 15:202-232.
27. Studer H, Derwahl M 1995 Mechanisms of non-neoplastic endocrine hyperplasia and hyperfunction: A changing concept. Endocr Rev 16:411-426.
28. 1 is a negative regulator for differentiated thyroid cancer: Studies of growth, migration, invasion and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocrinol Metab 79:806-813.
29. Filmus J, Zhao J, Buick RN 1992 Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TBF-β1) and alters the number and type of TGF-beta1 receptors in rat intestinal cell clones. Oncogene 7:521-526.
30. 1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol 76:13-21.
31. 1). J Endocrinol 149: 485-496.
32. Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Colletta G 1997 Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein. Cancer Res 57:2071-2076.
33. Peter HJ, Gerber H, Studer H, Smeds S 1985 Pathogenesis of heterogeneity in human multinodular goiter. J Clin Invest 76:1992-2002.
34. Studer H, Peter HJ, Gerber H 1989 Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125-135.
35. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H 1994 Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79:134-139.